A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Completed
354 enrolled
TraveraRTGx
Completed
72 enrolled
PROACTION:
Recruiting
4,500 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
DP-04
Recruiting
100 enrolled
OVAmiARN
Active not recruiting
746 enrolled
OLIVIA
Recruiting
250 enrolled
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
Recruiting
50 enrolled
SCOUT-1
Recruiting
750 enrolled
IREN
Recruiting
500 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
DUOLife
Recruiting
150 enrolled
BASECAMP-1
Recruiting
200 enrolled
FORCE
Not yet recruiting
200 enrolled
SMARAGD
Recruiting
1,975 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
HERGYN
Completed
509 enrolled
Clinical Pre-screening Protocol for Ovarian Cancer
Recruiting
60 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
OVAL-1
Completed
342 enrolled
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Recruiting
3,000 enrolled
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Completed
1,950 enrolled
ORACLE
Recruiting
2,020 enrolled
OLAP
Completed
661 enrolled
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Terminated
19 enrolled
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
RETRACE
Recruiting
200 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
OVARD
Active not recruiting
400 enrolled
START
Terminated
10 enrolled
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
Completed
2,506 enrolled
CYCLE_ENDO
Not yet recruiting
200 enrolled
BARHYSTER
Recruiting
132 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
PREFER
Completed
1,429 enrolled
ChemoINtel
Recruiting
100 enrolled
INSPIRE
Recruiting
5,350 enrolled
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Recruiting
1,000 enrolled
GynRNA
Recruiting
2,500 enrolled
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
Active not recruiting
5,372 enrolled
ROOT
Completed
167 enrolled